Replies to post #298678 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

LOVE IT: 100,000,000 users x 365 days x $1.00 profit margin gives a total continuing annual income to Anavex Life Sciences of $36.5 billion dollars.

If the company had 100 million shares in circulation (66.96 million shares presently are in issue), that would be $365 of cleared sales revenue for each AVXL share. Use your own Price to Earnings Ratio to calculate, then, a probable AVXL share price.

25 multiple is $9.125 per share.

Love it when you talk dirty...

[NWDR]

Completely agree that the potential revenue projections for Anavex are staggering.

I believe what we as investors must do now is focus on this statement in your post;

"Not the kind of thing that should guide the taking of an AVXL ownership position right now. There are lots of more relevant and controlling other data on that presently available for intelligent investments in AVXL equity positions."

Given that the potential revenue streams to Anavex are staggering, what is the possibility that those revenue streams will be realized. Just because I can return $10M or more for each dollar invested (gambled) in the lottery doesn't mean I should risk any significant sum of money. In fact, for a lottery investment I should consider the invested money the same as if I used the cash for fire kindling.

For Anavex, as you've pointed out and as I believe the continuing pre-clinical and clinical data continues to prove, is that the company is being rapidly de-risked. Each data set and latest lab experiments build a higher and higher base of understand and effectiveness for the company's pipeline.

Looking forward to the next few years.

Cheers

ps. GO AVXL